Regulation of the PU.1 gene by distal elements

Blood

Volumn 98, Issue 10, 2001, Pages 2958-2965

  Li, Youlin ^a,b,c,d   Okuno, Yutaka ^a,b,c,d   Zhang, Pu ^a,b,c,d   Radomska, Hanna S ^a,b,c,d   Chen, Hui Min ^a,b,c,d   Iwasaki, Hiromi ^a,b,c,d   Akashi, Koichi ^a,b,c,d   Klemsz, Michael J ^a,b,c,d   McKercher, Scott R ^a,b,c,d   Maki, Richard A ^a,b,c,d   Tenen, Daniel G ^a,b,c,d,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d BURNHAM INSTITUTE   (United States)

^e HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DNA FRAGMENT; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; ERYTHROLEUKEMIA; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; GENOME; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0035892121     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.10.2958     Document Type: Article

References (52)

1. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell. 1990;61:113-124.
2. Moreau-Gachelin F, Ray D, Mattei MG, Tambourin P, Tavitian A. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene. 1989;4:1449-1456.
3. Tenen DG, Hromas R, Licht JD, Zhang D-E. Transcription factors, normal myeloid development, and leukemia. Blood. 1997;90:489-519.
4. Pahl HL, Scheibe RJ, Zhang D-E, et al. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem. 1993;268:5014-5020.
5. Scott EW, Simon MC, Anastai J, Singh H. The transcription factor PU.1 is required for the development of multiple hematopoietic lineages. Science. 1994;265:1573-1577.
6. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996;15:5647-5658.
7. Zhang D-E, Hetherington CJ, Chen HM, Tenen DG. The macrophage transcription factor PU.1 directs tissue specific expression of the macrophage colony stimulating factor receptor. Mol Cell Biol. 1994;14:373-381.
8. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang D-E, Tenen DG. PU.1 (Spi-1) and C/EBPα regulate the expression of the granulocyte-macrophage colony-stimuating factor receptor α gene. Mol Cell Biol. 1995;15:5830-5845.
9. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood. 1996;88:1234-1247.
10. Iwama A, Zhang P, Darlington GJ, McKercher SR, Maki RA, Tenen DG. Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPα. Nucleic Acids Res. 1998;26:3034-3043.
11. Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA, Torbett BE. Myeloid development is selectively disrupted in PU.1 null mice. Blood. 1998;91:3702-3710.
12. Anderson KL, Smith KA, Perkin H, et al. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood. 1999;94:2310-2318.
13. DeKoter RP, Walsh JC, Singh H. PU.1 regulates both cytokine dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 1998;17:4456-4468.
14. Galson DL, Hensold JO, Bishop TR, et al. Mouse β-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol Cell Biol. 1993;13:2929-2941.
15. Voso MT, Burn TC, Wulf G, Lim B, Leone G, Tenen DG. Inhibition of hematopoiesis by competitive binding of the transcription factor PU.1. Proc Natl Acad Sci U S A. 1994;91:7932-7936.
16. Hromas R, Orazi A, Neiman RS, et al. Hematopoietic lineage-restricted and stage-restricted expression of the ETS oncogene family member PU.1. Blood. 1993;82:2998-3004.
17. Chen HM, Zhang P, Voso MT, et al. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood. 1995;85:2918-2928.
18. Moreau-Gachelin F, Tavitian A, Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature. 1988;331:277-280.
19. Paul R, Schuetze S, Kozak SL, Kozak CA, Kabat D. The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J Virol. 1991;65:464-467.
20. Moreau-Gachelin F, Wendling F, Molina T, et al. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol. 1996;16:2453-2463.
21. Rekhtman N, Radparvar F, Evans T, Skoultchi Al. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 1999;13:1398-1411.
22. Yamada T, Kihara-Negishi F, Yamamoto H, Yamamoto M, Hashimoto Y, Olkawa T. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells. Exp Cell Res. 1998;245:186-194.
23. Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1 Proc Natl Acad Sci U S A. 1999;96:8705-8710.
24. Zhang P, Zhang X, Iwama A, et al. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood. 2000;96:2641-2648.
25. Chen HM, Ray-Gallet D, Zhang P, et al. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene. 1995;11:1549-1560.
26. Chen HM, Zhang P, Radomska HS, Hetherington CJ, Zhang D-E, Tenen DG. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter. J Biol Chem. 1996;271:15743-15752.
27. Wang X, Scott EW, Sawyers CL, Friedman AD. C/EBPα bypasses granulocyte colony-stimulating factor signals to rapidly Induce PU.1 gene expression, stimulate granulocytic differentiation, and limit proliferation in 32D cl3 myeloblasts. Blood. 1999;94:560-571.
28. Amaravadi L, Klemsz MJ. DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol. 1999;18:875-884.
29. Dexter TM, Allen TD, Scott D, Teich NM. Isolation and characterisation of a bipotential haematopoietic cell line. Nature. 1979;277:471-474.
30. Ralph P. Retention of lymphocyte characteristics by myelomas and theta + -lymphomas: sensitivity to cortisol and phytohemagglutinin. J Immunol. 1973;110:1470-1475.
31. Dziennis S, Van Etten RA, Pahl HL, et al. The CD11b promoter directs high level expression of reporter genes in macrophages in transgenic mice. Blood. 1995;85:319-329.
32. Yang XW, Model P, Heintz N. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat Biotechnol. 1997;15:859-865.
33. Pahl HL, Burn TC, Tenen DG. Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. Exp Hematol. 1991;19:1038-1041.
34. Behre G, Smith LT, Tenen DG. Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation. Biotechniques. 1999;26:24-28.
35. Nakayama K, Negishi I, Kuida K, et al. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science. 1993;261:1584-1588.
36. Radomska HS, Satterthwaite AB, Burn TC, Cliff IA, Huettner CS, Tenen DG. Multiple control elements are required for expression of the human CD34 gene. Gene. 1998;222:305-318.
37. Nordeen SK. Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 1988;6:454-458.
38. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources rich in ribonuclease. Biochemistry. 1979;18:5294-5299.
39. Fort P, Marty L, Piechaczyk M, et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 1985;13:1431-1442.
40. Lagasse E, Weissman IL. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med. 1994;179:1047-1052.
41. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A. 1996;93:12355-12358.
42. Grosveld F, van Assendelft GB, Greaves DR, Köllias G. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell. 1987;51:975-985.
43. Diaz P, Cado D, Winoto A. A locus control region in the T cell receptor α/δ locus. Immunity. 1994;1:207-217.
44. Aronow BJ, Silbiger RN, Dusing MR, et al. Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol Cell Biol. 1992;12:4170-4185.
45. Fiering S, Kim CG, Epner EM, Groudine M. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the β-globin locus control region. Proc Natl Acad Sci U S A. 1993;90:8469-8473.
46. Peterson KR, Clegg CH, Huxley C, et al. Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human β-globin locus display proper developmental control of human globin genes. Proc Natl Acad Sci U S A. 1993;90:7593-7597.
47. Burn TC, Satterthwaite AB, Tenen DG. The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood. 1992;80:3051-3059.
48. Felsenfeld G. Chromatin as an essential part of the transcriptional mechanism. Nature. 1992;355:219-224.
49. Jimenez G, Griffiths SD, Ford AM, Greaves MF, Enver T. Activation of the β-globin locus control region precedes commitment to the erythroid lineage. Proc Natl Acad Sci U S A. 1992;89:10618-10622.
50. Gottgens B, McLaughlin F, Bockamp EO, et al. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements. Oncogene. 1997;15:2419-2428.
51. Groudine M, Kohwi-Shigematsu T, Gelinas R, Stamatoyannopoulos G, Papayannopoulou T. Human fetal to adult hemoglobin switching: changes in chromatin structure of the β-globin gene locus. Proc Natl Acad Sci U S A. 1983;80:7551-7555.
52. Tanimoto K, Liu Q, Bungert J, Engel JD. Effects of altered gene order or orientation of the locus control region on human β-globin gene expression in mice. Nature. 1999;398:344-348.